| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | General Counsel | Common Stock | 0 | $20.00 | Mar 2, 2023 | Direct | |
| OPIANT PHARMACEUTICALS, INC. | General Counsel | Stock Option (right to buy) | 0 | $10.00 | Mar 2, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OPNT | OPIANT PHARMACEUTICALS, INC. | Mar 2, 2023 | 6 | -$680K | 4 | Mar 3, 2023 | General Counsel |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Jan 27, 2023 | 1 | -$9K | 4 | Jan 31, 2023 | General Counsel |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Jan 5, 2023 | 1 | -$26.5K | 4 | Jan 5, 2023 | General Counsel |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Jul 14, 2022 | 1 | -$7.71K | 4 | Jul 15, 2022 | General Counsel |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Jun 27, 2022 | 1 | $0 | 4 | Jun 29, 2022 | General Counsel |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Jun 2, 2022 | 1 | -$15.5K | 4 | Jun 6, 2022 | General Counsel |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Jan 4, 2022 | 1 | $0 | 4 | Jan 5, 2022 | General Counsel |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Sep 14, 2021 | 2 | $25K | 4 | Sep 14, 2021 | General Counsel |